Back to search
FDAFDA · Food and drugs·Recall number D-0396-2019

Hydroxyprogesterone liquid, 250mg/ml, RX, glass vial

Published January 9, 2019 · Recall initiated: January 2, 2019

Summary

FDA records drug Class II recall D-0396-2019, published January 9, 2019 and initiated January 2, 2019. Recalling firm: Hiers Enterprises, LLC dba Northwest Compounding Pharmacy; Status: Terminated; Reported quantity: 20 ml; Lot: 10252018@24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
Distributor
Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.
Lot
10252018@24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydroxyprogesterone liquid, 250mg/ml, RX, glass vial recalled?

Yes. FDA published recall D-0396-2019 on January 9, 2019. Reported hazard: Lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter